| Year |
Citation |
Score |
| 2020 |
Cunningham JW, Ferreira JP, Deng H, Anker SD, Byra WM, Cleland JGF, Gheorghiade M, Lam CSP, La Police D, Mehra MR, Neaton JD, Spiro TE, van Veldhuisen DJ, Greenberg B, Zannad F. Natriuretic Peptide-Based Inclusion Criteria in a Heart Failure Clinical Trial: Insights From COMMANDER HF. Jacc. Heart Failure. PMID 32171760 DOI: 10.1016/J.Jchf.2019.12.009 |
0.328 |
|
| 2019 |
Ghazi L, Baker JV, Sharma S, Jain MK, Palfreeman A, Necsoi C, Murray DD, Neaton JD, Drawz PE. Role of Inflammatory Biomarkers in the Prevalence and Incidence of Hypertension Among HIV-Positive Participants in the START Trial. American Journal of Hypertension. PMID 31800000 DOI: 10.1093/Ajh/Hpz132 |
0.352 |
|
| 2019 |
Kotalik A, Eaton A, Lian Q, Serrano C, Connett J, Neaton JD. A win ratio approach to the re-analysis of Multiple Risk Factor Intervention Trial. Clinical Trials (London, England). 1740774519868233. PMID 31389723 DOI: 10.1177/1740774519868233 |
0.32 |
|
| 2019 |
Castillo-Mancilla JR, Phillips AN, Neaton JD, Neuhaus J, Sharma S, Baker JV, Collins S, Mannheimer S, Pett S, Touzeau-Römer V, Polizzotto MN, Lundgren JD, Gardner EM. Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START study. Journal of the International Aids Society. 22: e25297. PMID 31250552 DOI: 10.1002/Jia2.25297 |
0.337 |
|
| 2019 |
Sharma S, Schlusser KE, de la Torre P, Tambussi G, Draenert R, Pinto AN, Metcalf JA, Neaton JD, Laeyendecker O. The benefit of immediate compared with deferred antiretroviral therapy on CD4+ cell count recovery in early HIV infection. Aids (London, England). 33: 1335-1344. PMID 31157663 DOI: 10.1097/Qad.0000000000002219 |
0.339 |
|
| 2019 |
Lodi S, Phillips A, Lundgren J, Logan R, Sharma S, Cole SR, Babiker A, Law M, Chu H, Byrne D, Horban A, Sterne JAC, Porter K, Sabin C, Costagliola D, ... ... Neaton JD, et al. Effect estimates in randomized trials and observational studies: comparing apples with apples. American Journal of Epidemiology. PMID 31063192 DOI: 10.1093/Aje/Kwz100 |
0.341 |
|
| 2019 |
Greenberg B, Neaton JD, Anker SD, Byra WM, Cleland JGF, Deng H, Fu M, La Police DA, Lam CSP, Mehra MR, Nessel CC, Spiro TE, van Veldhuisen DJ, Vanden Boom CM, Zannad F. Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm: A Post Hoc Analysis of the COMMANDER HF Trial. Jama Cardiology. PMID 31017637 DOI: 10.1001/Jamacardio.2019.1049 |
0.334 |
|
| 2019 |
Boatman JA, Baker JV, Emery S, Furrer H, Mushatt DM, Sedlacek D, Lundgren JD, Neaton JD. Risk Factors for Low CD4+ Count Recovery Despite Viral Suppression among Participants Initiating Antiretroviral Treatment with CD4+ Counts > 500 cells/mm3: Findings from the Strategic Timing of AntiRetroviral Treatment (START) Trial. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 30664075 DOI: 10.1097/Qai.0000000000001967 |
0.321 |
|
| 2019 |
Ghazi L, Baker JV, Sharma S, Jain MK, Palfreeman A, Necsoi C, Murray D, Neaton JD, Drawz PE. Abstract P172: Association of Interleukin 6 With Hypertension in HIV Positive Participants in the Strategic Timing of Antiretroviral Treatment (START) Trial Circulation. 139. DOI: 10.1161/Circ.139.Suppl_1.P172 |
0.376 |
|
| 2019 |
Blumberg E, Gary C, Young JH, Nguyen M, Michonneau D, Temesgem Z, Origuen J, Barcan L, Obeid K, Belloso W, Gras J, Corbelli GM, Neaton J, Lundgren J, Snydman DR, et al. 2670. Clostridioides difficile Infection (CDI) in Solid-Organ (SOT) and Hematopoietic Stem Cell Transplant (HCT) Recipients: A Prospective Multinational Study Open Forum Infectious Diseases. 6: S936-S936. DOI: 10.1093/Ofid/Ofz360.2348 |
0.32 |
|
| 2018 |
Zannad F, Anker SD, Byra WM, Cleland JGF, Fu M, Gheorghiade M, Lam CSP, Mehra MR, Neaton JD, Nessel CC, Spiro TE, van Veldhuisen DJ, Greenberg B. Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease. The New England Journal of Medicine. PMID 30146935 DOI: 10.1056/Nejmoa1808848 |
0.336 |
|
| 2018 |
Borges ÁH, Neuhaus J, Sharma S, Neaton JD, Henry K, Anagnostou O, Staub T, Emery S, Lundgren JD. The effect of interrupted/deferred antiretroviral therapy on disease risk: a SMART & START combined analysis. The Journal of Infectious Diseases. PMID 30032171 DOI: 10.1093/Infdis/Jiy442 |
0.334 |
|
| 2018 |
Lutsey PL, Chen LY, Eaton A, Jaeb M, Rudser KD, Neaton JD, Alonso A. A Pilot Randomized Trial of Oral Magnesium Supplementation on Supraventricular Arrhythmias. Nutrients. 10. PMID 29996476 DOI: 10.3390/Nu10070884 |
0.336 |
|
| 2018 |
Gnatiuc L, Herrington W, Halsey J, Tuomilehto J, Fang X, Kim H, Bacquer DD, Dobson A, Criqui M, Jacobs, Leon D, Peters S, Ueshima H, Sherliker P, Peto R, ... ... Neaton J, et al. Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies The Lancet Diabetes & Endocrinology. 6: 538-546. PMID 29752194 DOI: 10.1016/S2213-8587(18)30079-2 |
0.349 |
|
| 2018 |
Neaton JD, Grund B, Wentworth D. How to construct an optimal interim report: What the data monitoring committee does and doesn't need to know. Clinical Trials (London, England). 1740774518764449. PMID 29552920 DOI: 10.1177/1740774518764449 |
0.324 |
|
| 2018 |
Lundgren JD, Borges AH, Neaton JD. Serious Non-AIDS Conditions in HIV: Benefit of Early ART. Current Hiv/Aids Reports. PMID 29504063 DOI: 10.1007/S11904-018-0387-Y |
0.36 |
|
| 2018 |
Schlusser KE, Sharma S, de la Torre P, Tambussi G, Draenert R, Pinto AN, Metcalf JA, German D, Neaton JD, Laeyendecker O. Comparison of Self-report to Biomarkers of Recent HIV Infection: Findings from the START Trial. Aids and Behavior. PMID 29427230 DOI: 10.1007/S10461-018-2048-Y |
0.34 |
|
| 2018 |
Castillo-Mancilla JR, Phillips AN, Neaton JD, Neuhaus J, Collins S, Mannheimer S, Pett S, Touzeau-Römer V, Polizzotto MN, Lundgren JD, Gardner EM. Association of Suboptimal Antiretroviral Therapy Adherence With Inflammation in Virologically Suppressed Individuals Enrolled in the SMART Study. Open Forum Infectious Diseases. 5: ofx275. PMID 29362724 DOI: 10.1093/Ofid/Ofx275 |
0.336 |
|
| 2018 |
Molina JM, Grund B, Gordin F, Williams I, Schechter M, Losso M, Law M, Ekong E, Mwelase N, Skoutelis A, Wiselka MJ, Vandekerckhove L, Benfield T, Munroe D, Lundgren JD, ... Neaton JD, et al. Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial. The Lancet. Hiv. PMID 29352723 DOI: 10.1016/S2352-3018(18)30003-1 |
0.345 |
|
| 2018 |
Ekenberg C, Tang ME, Murray DD, MacPherson C, Sherman BT, Losso M, Wood R, Paredes R, Molina J, Helleberg M, Jina N, Kityo CM, Florence E, Polizzotto MN, Neaton JD, et al. 1284. Study of Single Nucleotide Polymorphisms Associated with HIV-1 Set-Point Viral Load in Antiretroviral Therapy-Naïve HIV-Positive Participants of the START Study Open Forum Infectious Diseases. 5: S392-S392. DOI: 10.1093/Ofid/Ofy210.1117 |
0.331 |
|
| 2018 |
Greenberg B, Anker S, Byra WM, Cleland JG, Fu M, Gheorghiade M, Lam CS, Mehra MR, Neaton JD, Nessel CC, Spiro T, van Veldhuisen DJ, Zannad F. A Randomized Study Comparing Rivaroxaban with Placebo in Subjects with Heart Failure and Significant Coronary Artery Disease Following an Episode of Decompensated Heart Failure: The COMMANDER HF study Journal of Cardiac Failure. 24: 811. DOI: 10.1016/J.Cardfail.2018.11.006 |
0.372 |
|
| 2017 |
Hart BB, Nordell AD, Okulicz JF, Palfreeman A, Horban A, Kedem E, Neuhaus J, Jacobs DR, Duprez DA, Neaton JD. Inflammation Related Morbidity and Mortality Among HIV-Positive Adults: How Extensive Is It? Journal of Acquired Immune Deficiency Syndromes (1999). PMID 28991883 DOI: 10.1097/Qai.0000000000001554 |
0.363 |
|
| 2016 |
Lodi S, Sharma S, Lundgren JD, Phillips AN, Cole SR, Logan R, Agan BK, Babiker A, Klinker H, Chu H, Law M, Neaton JD, Hernán MA. The per-protocol effect of immediate versus deferred antiretroviral therapy initiation. Aids (London, England). 30: 2659-2663. PMID 27782964 DOI: 10.1097/Qad.0000000000001243 |
0.361 |
|
| 2016 |
Davey RT, Dodd L, Proschan MA, Neaton J, Neuhaus Nordwall J, Koopmeiners JS, Beigel J, Tierney J, Lane HC, Fauci AS, Massaquoi MBF, Sahr F, Malvy D. A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection. The New England Journal of Medicine. 375: 1448-1456. PMID 27732819 DOI: 10.1056/Nejmoa1604330 |
0.302 |
|
| 2016 |
Grund B, Baker JV, Deeks SG, Wolfson J, Wentworth D, Cozzi-Lepri A, Cohen CJ, Phillips A, Lundgren JD, Neaton JD. Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy. Plos One. 11: e0155100. PMID 27171281 DOI: 10.1371/Journal.Pone.0155100 |
0.379 |
|
| 2016 |
Borges ÁH, O'Connor JL, Phillips AN, Neaton JD, Grund B, Neuhaus J, Vjecha MJ, Calmy A, Koelsch KK, Lundgren JD. IL-6 is a stronger predictor of clinical events than hsCRP or D-dimer during HIV infection. The Journal of Infectious Diseases. PMID 27132283 DOI: 10.1093/Infdis/Jiw173 |
0.328 |
|
| 2016 |
Kuller LH, Neaton JD. Letter by Kuller and Neaton Regarding Article, "Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans". Circulation. 133: e452. PMID 27002092 DOI: 10.1161/Circulationaha.115.020379 |
0.315 |
|
| 2016 |
Dodd LE, Proschan MA, Neuhaus J, Koopmeiners JS, Neaton J, Beigel JD, Barrett K, Lane HC, Davey RT. Design of a Randomized Controlled Trial for Ebola Virus Disease Medical Countermeasures: PREVAIL II, the Ebola MCM Study. The Journal of Infectious Diseases. PMID 26908739 DOI: 10.1093/Infdis/Jiw061 |
0.308 |
|
| 2016 |
Lundgren J, Babiker AG, Neaton JD. Antiretroviral Therapy in Early HIV Infection. The New England Journal of Medicine. 374: 394. PMID 26816019 DOI: 10.1056/Nejmc1513311 |
0.353 |
|
| 2016 |
Kennedy SB, Neaton JD, Lane HC, Kieh MW, Massaquoi MB, Touchette NA, Nason MC, Follmann DA, Boley FK, Johnson MP, Larson G, Kateh FN, Nyenswah TG. Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challenges. Clinical Trials (London, England). PMID 26768572 DOI: 10.1177/1740774515621037 |
0.302 |
|
| 2016 |
Brummel-Ziedins KE, Baker JV, Gissel M, Neuhaus J, Neaton JD, Tracy RP. Thrombin Generation: Plasma Composition Imbalance and Mortality in HIV Blood. 128: 3768-3768. DOI: 10.1182/Blood.V128.22.3768.3768 |
0.363 |
|
| 2016 |
Boatman J, Baker J, Emery S, Mushatt D, Furrer H, Sedláček D, Lundgren J, Neaton J. Risk Factors for Low Immune Recovery Among Participants with CD4+ Counts > 500 cells/mm3 who Achieved Viral Suppression in the Immediate Antiretroviral Treatment (ART) Group in Strategic Timing of Antiretroviral Treatment (START) Trial Open Forum Infectious Diseases. 3. DOI: 10.1093/Ofid/Ofw172.1223 |
0.343 |
|
| 2015 |
Cummins NW, Neuhaus J, Chu H, Neaton J, Wyen C, Rockstroh JK, Skiest DJ, Boyd MA, Khoo S, Rotger M, Telenti A, Weinshilboum R, Badley AD. Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis. Ebiomedicine. 2: 706-12. PMID 26288843 DOI: 10.1016/J.Ebiom.2015.05.012 |
0.318 |
|
| 2015 |
Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, Avihingsanon A, Cooper DA, Fätkenheuer G, Llibre JM, Molina JM, Munderi P, Schechter M, Wood R, ... ... Neaton JD, et al. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. The New England Journal of Medicine. 373: 795-807. PMID 26192873 DOI: 10.1056/Nejmoa1506816 |
0.394 |
|
| 2015 |
Maduna PH, Dolan M, Kondlo L, Mabuza H, Dlamini JN, Polis M, Mnisi T, Orsega S, Maja P, Ledwaba L, Molefe T, Sangweni P, Malan L, Matchaba G, Khabo P, ... ... Neaton JD, et al. Morbidity and mortality according to latest CD4+ cell count among HIV positive individuals in South Africa who enrolled in project Phidisa. Plos One. 10: e0121843. PMID 25856495 DOI: 10.1371/Journal.Pone.0121843 |
0.368 |
|
| 2015 |
Soliman EZ, Sharma S, Arastéh K, Wohl D, Achhra A, Tambussi G, O'Connor J, Stein JH, Duprez DA, Neaton JD, Phillips A. Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. Hiv Medicine. 16: 46-54. PMID 25711323 DOI: 10.1111/Hiv.12233 |
0.385 |
|
| 2015 |
Lundgren J, Babiker A, Gordin F, Emery S, Fätkenheuer G, Molina JM, Wood R, Neaton JD. Why START? Reflections that led to the conduct of this large long-term strategic HIV trial. Hiv Medicine. 16: 1-9. PMID 25711317 DOI: 10.1111/Hiv.12227 |
0.347 |
|
| 2014 |
Young LC, Roediger MP, Grandits G, Baker J, Somboonwit C, Williams I, Lundgren JD, Neaton JD, Soliman EZ. Relationship between inflammatory and coagulation biomarkers and cardiac autonomic function in HIV-infected individuals. Biomarkers in Medicine. 8: 1073-83. PMID 25402578 DOI: 10.2217/Bmm.14.27 |
0.317 |
|
| 2014 |
Béténé A Dooko C, De Wit S, Neuhaus J, Palfreeman A, Pepe R, Pankow JS, Neaton JD. Interleukin-6, high sensitivity C-reactive protein, and the development of type 2 diabetes among HIV-positive patients taking antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes (1999). 67: 538-46. PMID 25393940 DOI: 10.1097/Qai.0000000000000354 |
0.333 |
|
| 2014 |
Borges ÁH, Weitz JI, Collins G, Baker JV, Lévy Y, Davey RT, Phillips AN, Neaton JD, Lundgren JD, Deeks SG. Markers of inflammation and activation of coagulation are associated with anaemia in antiretroviral-treated HIV disease. Aids (London, England). 28: 1791-6. PMID 25003720 DOI: 10.1097/Qad.0000000000000344 |
0.32 |
|
| 2014 |
Nordell AD, McKenna M, Borges ÃH, Duprez D, Neuhaus J, Neaton JD. Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation. Journal of the American Heart Association. 3: e000844. PMID 24870935 DOI: 10.1161/Jaha.114.000844 |
0.377 |
|
| 2014 |
Peters L, Neuhaus J, Duprez D, Neaton JD, Tracy R, Klein MB, Mocroft A, Rockstroh J, Dore G, Lundgren JD. Biomarkers of inflammation, coagulation and microbial translocation in HIV/HCV co-infected patients in the SMART study. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 60: 295-300. PMID 24793968 DOI: 10.1016/J.Jcv.2014.03.017 |
0.345 |
|
| 2014 |
Miller CJ, Baker JV, Bormann AM, Erlandson KM, Huppler Hullsiek K, Justice AC, Neuhaus J, Paredes R, Petoumenos K, Wentworth D, Winston A, Wolfson J, Neaton JD. Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy. Plos One. 9: e95061. PMID 24728071 DOI: 10.1371/Journal.Pone.0095061 |
0.395 |
|
| 2014 |
Sanfilippo KM, McTigue KM, Fidler CJ, Neaton JD, Chang Y, Fried LF, Liu S, Kuller LH. Hypertension and obesity and the risk of kidney cancer in 2 large cohorts of US men and women. Hypertension. 63: 934-41. PMID 24637660 DOI: 10.1161/Hypertensionaha.113.02953 |
0.333 |
|
| 2014 |
Cobb LK, Anderson CA, Elliott P, Hu FB, Liu K, Neaton JD, Whelton PK, Woodward M, Appel LJ. Methodological issues in cohort studies that relate sodium intake to cardiovascular disease outcomes: a science advisory from the American Heart Association. Circulation. 129: 1173-86. PMID 24515991 DOI: 10.1161/Cir.0000000000000015 |
0.308 |
|
| 2014 |
Dawood FZ, Roediger MP, Grandits G, Miller D, Fisher M, Zhang ZM, Hodder S, Hoy JF, Lundgren JD, Neaton JD, Soliman EZ. Determinants of developing widened spatial QRS-T angle in HIV-infected individuals: results from the Strategies for Management of Antiretroviral Therapy [SMART] Study. Journal of Electrocardiology. 47: 264-71. PMID 24406207 DOI: 10.1016/J.Jelectrocard.2013.12.001 |
0.338 |
|
| 2014 |
Zhang J, Carlin BP, Neaton JD, Soon GG, Nie L, Kane R, Virnig BA, Chu H. Network meta-analysis of randomized clinical trials: reporting the proper summaries. Clinical Trials (London, England). 11: 246-62. PMID 24096635 DOI: 10.1177/1740774513498322 |
0.317 |
|
| 2014 |
Neaton JD. HIV and cardiovascular disease: comment on Islam et al. Hiv Medicine. 14: 517-8. PMID 23910440 DOI: 10.1111/Hiv.12043 |
0.303 |
|
| 2013 |
Hatano H, Strain MC, Scherzer R, Bacchetti P, Wentworth D, Hoh R, Martin JN, McCune JM, Neaton JD, Tracy RP, Hsue PY, Richman DD, Deeks SG. Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial. The Journal of Infectious Diseases. 208: 1436-42. PMID 23975885 DOI: 10.1093/Infdis/Jit453 |
0.384 |
|
| 2013 |
Borges ÁH, Silverberg MJ, Wentworth D, Grulich AE, Fätkenheuer G, Mitsuyasu R, Tambussi G, Sabin CA, Neaton JD, Lundgren JD. Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers. Aids (London, England). 27: 1433-41. PMID 23945504 DOI: 10.1097/Qad.0B013E32835F6B0C |
0.329 |
|
| 2013 |
Baker JV, Brummel-Ziedins K, Neuhaus J, Duprez D, Cummins N, Dalmau D, DeHovitz J, Lehmann C, Sullivan A, Woolley I, Kuller L, Neaton JD, Tracy RP. HIV replication alters the composition of extrinsic pathway coagulation factors and increases thrombin generation. Journal of the American Heart Association. 2: e000264. PMID 23896681 DOI: 10.1161/Jaha.113.000264 |
0.359 |
|
| 2013 |
Lundgren JD, Babiker AG, Gordin FM, Borges ÁH, Neaton JD. When to start antiretroviral therapy: the need for an evidence base during early HIV infection. Bmc Medicine. 11: 148. PMID 23767777 DOI: 10.1186/1741-7015-11-148 |
0.378 |
|
| 2013 |
Rotger M, Glass TR, Junier T, Lundgren J, Neaton JD, Poloni ES, van 't Wout AB, Lubomirov R, Colombo S, Martinez R, Rauch A, Günthard HF, Neuhaus J, Wentworth D, van Manen D, et al. Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: 112-21. PMID 23532479 DOI: 10.1093/Cid/Cit196 |
0.365 |
|
| 2013 |
Soliman EZ, Roediger MP, Duprez DA, Knobel H, Elion R, Neaton JD. Protease inhibitors and cardiac autonomic function in HIV-infected patients: a cross-sectional analysis from the Strategies for Management of Antiretroviral Therapy (SMART) Trial. Bmj Open. 3. PMID 23471611 DOI: 10.1136/Bmjopen-2012-002523 |
0.349 |
|
| 2013 |
Gupta M, Miller CJ, Baker JV, Lazar J, Bogner JR, Calmy A, Soliman EZ, Neaton JD. Biomarkers and electrocardiographic evidence of myocardial ischemia in patients with human immunodeficiency virus infection. The American Journal of Cardiology. 111: 760-4. PMID 23276469 DOI: 10.1016/J.Amjcard.2012.11.032 |
0.342 |
|
| 2013 |
Dawood FZ, Khan F, Roediger MP, Zhang ZM, Swaminathan S, Klinker H, Hoy J, Lundgren JD, Neaton JD, Soliman EZ. Electrocardiographic spatial QRS-T angle and incident cardiovascular disease in HIV-infected patients (from the Strategies for the Management of Antiretroviral Therapy [SMART] study). The American Journal of Cardiology. 111: 118-24. PMID 23062314 DOI: 10.1016/J.Amjcard.2012.08.054 |
0.364 |
|
| 2013 |
Babiker AG, Emery S, Fätkenheuer G, Gordin FM, Grund B, Lundgren JD, Neaton JD, Pett SL, Phillips A, Touloumi G, Vjechaj MJ. Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study. Clinical Trials (London, England). 10: S5-S36. PMID 22547421 DOI: 10.1177/1740774512440342 |
0.393 |
|
| 2012 |
Stamler J, Neaton JD, Cohen JD, Cutler J, Eberly L, Grandits G, Kuller LH, Ockene J, Prineas R. Multiple risk factor intervention trial revisited: a new perspective based on nonfatal and fatal composite endpoints, coronary and cardiovascular, during the trial. Journal of the American Heart Association. 1: e003640. PMID 23316301 DOI: 10.1161/Jaha.112.003640 |
0.369 |
|
| 2012 |
Kiernan MS, Wentworth D, Francis G, Martinez FA, Dickstein K, Komajda M, Zannad F, Neaton JD, Konstam MA. Predicting adverse events during angiotensin receptor blocker treatment in heart failure: results from the HEAAL trial. European Journal of Heart Failure. 14: 1401-9. PMID 23187648 DOI: 10.1093/Eurjhf/Hfs145 |
0.347 |
|
| 2012 |
Baker JV, Huppler Hullsiek K, Prosser R, Duprez D, Grimm R, Tracy RP, Rhame F, Henry K, Neaton JD. Angiotensin converting enzyme inhibitor and HMG-CoA reductase inhibitor as adjunct treatment for persons with HIV infection: a feasibility randomized trial. Plos One. 7: e46894. PMID 23082133 DOI: 10.1371/Journal.Pone.0046894 |
0.403 |
|
| 2012 |
Little RJ, D'Agostino R, Cohen ML, Dickersin K, Emerson SS, Farrar JT, Frangakis C, Hogan JW, Molenberghs G, Murphy SA, Neaton JD, Rotnitzky A, Scharfstein D, Shih WJ, Siegel JP, et al. The prevention and treatment of missing data in clinical trials. The New England Journal of Medicine. 367: 1355-60. PMID 23034025 DOI: 10.1056/Nejmsr1203730 |
0.316 |
|
| 2012 |
Duprez DA, Neuhaus J, Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Nixon D, Paton NI, Prineas RJ, Neaton JD. Inflammation, coagulation and cardiovascular disease in HIV-infected individuals. Plos One. 7: e44454. PMID 22970224 DOI: 10.1371/journal.pone.0044454 |
0.31 |
|
| 2012 |
Little RJ, Cohen ML, Dickersin K, Emerson SS, Farrar JT, Neaton JD, Shih W, Siegel JP, Stern H. The design and conduct of clinical trials to limit missing data. Statistics in Medicine. 31: 3433-43. PMID 22829439 DOI: 10.1002/Sim.5519 |
0.314 |
|
| 2012 |
Ledwaba L, Tavel JA, Khabo P, Maja P, Qin J, Sangweni P, Liu X, Follmann D, Metcalf JA, Orsega S, Baseler B, Neaton JD, Lane HC. Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV disease. Plos One. 7: e24243. PMID 22448211 DOI: 10.1371/Journal.Pone.0024243 |
0.386 |
|
| 2012 |
Baker JV, Neuhaus J, Duprez D, Freiberg M, Bernardino JI, Badley AD, Nixon DE, Lundgren JD, Tracy RP, Neaton JD. HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction. Journal of Acquired Immune Deficiency Syndromes (1999). 60: 128-34. PMID 22421746 DOI: 10.1097/Qai.0B013E318252F99F |
0.381 |
|
| 2011 |
Ernst ME, Neaton JD, Grimm RH, Collins G, Thomas W, Soliman EZ, Prineas RJ. Long-term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the multiple risk factor intervention trial. Hypertension. 58: 1001-7. PMID 22025372 DOI: 10.1161/Hypertensionaha.111.181248 |
0.334 |
|
| 2011 |
Rodgers A, Patel A, Berwanger O, Bots M, Grimm R, Grobbee DE, Jackson R, Neal B, Neaton J, Poulter N, Rafter N, Raju PK, Reddy S, Thom S, et al. An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk. Plos One. 6: e19857. PMID 21647425 DOI: 10.1371/Journal.Pone.0019857 |
0.384 |
|
| 2011 |
Boulware DR, Hullsiek KH, Puronen CE, Rupert A, Baker JV, French MA, Bohjanen PR, Novak RM, Neaton JD, Sereti I. Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death. The Journal of Infectious Diseases. 203: 1637-46. PMID 21592994 DOI: 10.1093/Infdis/Jir134 |
0.388 |
|
| 2011 |
Sandler NG, Wand H, Roque A, Law M, Nason MC, Nixon DE, Pedersen C, Ruxrungtham K, Lewin SR, Emery S, Neaton JD, Brenchley JM, Deeks SG, Sereti I, Douek DC, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. The Journal of Infectious Diseases. 203: 780-90. PMID 21252259 DOI: 10.1093/Infdis/Jiq118 |
0.366 |
|
| 2011 |
Duprez DA, Neuhaus J, Tracy R, Kuller LH, Deeks SG, Orkin C, Stoehr A, Woolley IJ, Neaton JD. N-terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patients. Aids (London, England). 25: 651-7. PMID 21245726 DOI: 10.1097/Qad.0B013E32834404A1 |
0.363 |
|
| 2011 |
Soliman EZ, Prineas RJ, Roediger MP, Duprez DA, Boccara F, Boesecke C, Stephan C, Hodder S, Stein JH, Lundgren JD, Neaton JD. Prevalence and prognostic significance of ECG abnormalities in HIV-infected patients: results from the Strategies for Management of Antiretroviral Therapy study. Journal of Electrocardiology. 44: 779-85. PMID 21145066 DOI: 10.1016/J.Jelectrocard.2010.10.027 |
0.346 |
|
| 2011 |
Baker JV, Neuhaus J, Duprez D, Kuller LH, Tracy R, Belloso WH, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Nixon DE, Paton NI, Neaton JD. Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection. Journal of Acquired Immune Deficiency Syndromes (1999). 56: 36-43. PMID 20930640 DOI: 10.1097/Qai.0B013E3181F7F61A |
0.4 |
|
| 2010 |
Neaton JD, Neuhaus J, Emery S. Soluble biomarkers and morbidity and mortality among people infected with HIV: summary of published reports from 1997 to 2010. Current Opinion in Hiv and Aids. 5: 480-90. PMID 20978391 DOI: 10.1097/Coh.0B013E32833Ed75D |
0.368 |
|
| 2010 |
Ratsela A, Polis M, Dhlomo S, Emery S, Grandits G, Khabo P, Khanyile T, Komati S, Neaton JD, Naidoo LC, Magongoa D, Qolohle D. A randomized factorial trial comparing 4 treatment regimens in treatment-naive HIV-infected persons with AIDS and/or a CD4 cell count <200 cells/μL in South Africa. The Journal of Infectious Diseases. 202: 1529-37. PMID 20942650 DOI: 10.1086/656718 |
0.386 |
|
| 2010 |
Neaton JD, Babiker A, Bohnhorst M, Darbyshire J, Denning E, Frishman A, Grarup J, Larson G, Lundgren J. Regulatory impediments jeopardizing the conduct of clinical trials in Europe funded by the National Institutes of Health. Clinical Trials (London, England). 7: 705-18. PMID 20729252 DOI: 10.1177/1740774510376547 |
0.304 |
|
| 2010 |
Achhra AC, Amin J, Law MG, Emery S, Gerstoft J, Gordin FM, Vjecha MJ, Neaton JD, Cooper DA. Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients. Aids (London, England). 24: 1877-86. PMID 20588170 DOI: 10.1097/Qad.0B013E32833B1B26 |
0.375 |
|
| 2010 |
Baker J, Quick H, Hullsiek KH, Tracy R, Duprez D, Henry K, Neaton JD. Interleukin-6 and d-dimer levels are associated with vascular dysfunction in patients with untreated HIV infection. Hiv Medicine. 11: 608-9. PMID 20456504 DOI: 10.1111/J.1468-1293.2010.00835.X |
0.363 |
|
| 2010 |
Neuhaus J, Jacobs DR, Baker JV, Calmy A, Duprez D, La Rosa A, Kuller LH, Pett SL, Ristola M, Ross MJ, Shlipak MG, Tracy R, Neaton JD. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. The Journal of Infectious Diseases. 201: 1788-95. PMID 20446848 DOI: 10.1086/652749 |
0.361 |
|
| 2010 |
Baker J, Ayenew W, Quick H, Hullsiek KH, Tracy R, Henry K, Duprez D, Neaton JD. High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection. The Journal of Infectious Diseases. 201: 285-92. PMID 19954384 DOI: 10.1086/649560 |
0.368 |
|
| 2009 |
Abrams D, Lévy Y, Losso MH, Babiker A, Collins G, Cooper DA, Darbyshire J, Emery S, Fox L, Gordin F, Lane HC, Lundgren JD, Mitsuyasu R, ... Neaton JD, et al. Interleukin-2 therapy in patients with HIV infection. The New England Journal of Medicine. 361: 1548-59. PMID 19828532 DOI: 10.1056/Nejmoa0903175 |
0.34 |
|
| 2009 |
Baker JV, Duprez D, Rapkin J, Hullsiek KH, Quick H, Grimm R, Neaton JD, Henry K. Untreated HIV infection and large and small artery elasticity. Journal of Acquired Immune Deficiency Syndromes (1999). 52: 25-31. PMID 19731451 DOI: 10.1097/Qai.0B013E3181B02E6A |
0.372 |
|
| 2009 |
Baker JV, Henry WK, Neaton JD. The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms. Current Opinion in Hiv and Aids. 4: 176-82. PMID 19532047 DOI: 10.1097/Coh.0B013E328329C62F |
0.398 |
|
| 2009 |
Duprez DA, Kuller LH, Tracy R, Otvos J, Cooper DA, Hoy J, Neuhaus J, Paton NI, Friis-Moller N, Lampe F, Liappis AP, Neaton JD. Lipoprotein particle subclasses, cardiovascular disease and HIV infection. Atherosclerosis. 207: 524-9. PMID 19515371 DOI: 10.1016/J.Atherosclerosis.2009.05.001 |
0.378 |
|
| 2009 |
Lundgren JD, Phillips AN, Neaton J. Uncertainty as to whether the use of antiretroviral therapy for persons recently infected with HIV has a favorable risk-to-benefit ratio. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 48: 1162; author reply 1. PMID 19292638 DOI: 10.1086/597495 |
0.367 |
|
| 2008 |
Neaton JD, Grund B. Earlier initiation of antiretroviral therapy in treatment-naïve patients: implications of results of treatment interruption trials. Current Opinion in Hiv and Aids. 3: 112-7. PMID 19372951 DOI: 10.1097/Coh.0B013E3282F3808B |
0.304 |
|
| 2008 |
Phillips AN, Neaton J, Lundgren JD. The role of HIV in serious diseases other than AIDS. Aids (London, England). 22: 2409-18. PMID 19005264 DOI: 10.1097/Qad.0B013E3283174636 |
0.367 |
|
| 2008 |
Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Neuhaus J, Nixon D, Paton NI, Neaton JD. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. Plos Medicine. 5: e203. PMID 18942885 DOI: 10.1371/Journal.Pmed.0050203 |
0.394 |
|
| 2008 |
Stamler J, Neaton JD. The Multiple Risk Factor Intervention Trial (MRFIT)--importance then and now. Jama. 300: 1343-5. PMID 18799447 DOI: 10.1001/Jama.300.11.1343 |
0.364 |
|
| 2008 |
El-Sadr WM, Grund B, Neuhaus J, Babiker A, Cohen CJ, Darbyshire J, Emery S, Lundgren JD, Phillips A, Neaton JD. Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial. Annals of Internal Medicine. 149: 289-99. PMID 18765698 DOI: 10.7326/0003-4819-149-5-200809020-00003 |
0.371 |
|
| 2008 |
Baker JV, Peng G, Rapkin J, Krason D, Reilly C, Cavert WP, Abrams DI, MacArthur RD, Henry K, Neaton JD. Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases. Journal of Acquired Immune Deficiency Syndromes (1999). 48: 541-6. PMID 18645520 DOI: 10.1097/Qai.0B013E31817Bebb3 |
0.325 |
|
| 2008 |
Lundgren JD, Babiker A, El-Sadr W, Emery S, Grund B, Neaton JD, Neuhaus J, Phillips AN. Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up. The Journal of Infectious Diseases. 197: 1145-55. PMID 18476293 DOI: 10.1086/529523 |
0.364 |
|
| 2008 |
Adabag AS, Grandits GA, Prineas RJ, Crow RS, Bloomfield HE, Neaton JD. Relation of heart rate parameters during exercise test to sudden death and all-cause mortality in asymptomatic men. The American Journal of Cardiology. 101: 1437-43. PMID 18471455 DOI: 10.1016/J.Amjcard.2008.01.021 |
0.322 |
|
| 2008 |
Baker JV, Peng G, Rapkin J, Abrams DI, Silverberg MJ, MacArthur RD, Cavert WP, Henry WK, Neaton JD. CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection. Aids (London, England). 22: 841-8. PMID 18427202 DOI: 10.1097/Qad.0B013E3282F7Cb76 |
0.402 |
|
| 2008 |
Neaton JD, Lane HC. Getting personal about treating HIV. Nature Medicine. 14: 369-70. PMID 18391933 DOI: 10.1038/Nm0408-369 |
0.315 |
|
| 2007 |
Silverberg MJ, Neuhaus J, Bower M, Gey D, Hatzakis A, Henry K, Hidalgo J, Lourtau L, Neaton JD, Tambussi G, Abrams DI. Risk of cancers during interrupted antiretroviral therapy in the SMART study. Aids (London, England). 21: 1957-63. PMID 17721103 DOI: 10.1097/Qad.0B013E3282Ed6338 |
0.321 |
|
| 2007 |
Thomas AJ, Eberly LE, Neaton JD, Davey Smith G. Census-based and personally reported income measures as long-term risk-adjusted mortality predictors. Public Health. 121: 898-901. PMID 17606281 DOI: 10.1016/J.Puhe.2007.03.019 |
0.352 |
|
| 2007 |
Zhao Y, Grambsch PM, Neaton JD. A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome. Clinical Trials (London, England). 4: 140-53. PMID 17456513 DOI: 10.1177/1740774507076936 |
0.47 |
|
| 2007 |
Fox Z, Antunes F, Davey R, Gazzard B, Klimas N, Labriola A, Losso M, Neaton JD, Phillips A, Ruxrungtham K, Staszewski S, Weiss L, Lundgren DJ, Aguilar L, Angel EB, et al. Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count ≥ 300 cells/μL who were assigned to 7.5 MIU interleukin-2 Hiv Medicine. 8: 112-123. PMID 17352768 DOI: 10.1111/J.1468-1293.2007.00440.X |
0.319 |
|
| 2007 |
Terry PD, Abramson JL, Neaton JD. Blood pressure and risk of death from external causes among men screened for the Multiple Risk Factor Intervention Trial. American Journal of Epidemiology. 165: 294-301. PMID 17098820 DOI: 10.1093/Aje/Kwk014 |
0.343 |
|
| 2007 |
Kuller LH, Grandits G, Cohen JD, Neaton JD, Prineas R. Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome. Atherosclerosis. 195: 122-8. PMID 17011566 DOI: 10.1016/J.Atherosclerosis.2006.09.001 |
0.349 |
|
| 2007 |
Reekie J, Mocroft A, Neaton J, Lundgren JD. Clinical outcomes in clinical trials of anti-HIV treatment Future Hiv Therapy. 1: 251-258. DOI: 10.2217/17469600.1.3.251 |
0.394 |
|
| 2006 |
El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, Arduino RC, Babiker A, Burman W, Clumeck N, Cohen CJ, Cohn D, Cooper D, Darbyshire J, Emery S, Fätkenheuer G, et al. CD4+ count-guided interruption of antiretroviral treatment New England Journal of Medicine. 355: 2283-2296. PMID 17135583 DOI: 10.1056/Nejmoa062360 |
0.386 |
|
| 2006 |
Thomas AJ, Eberly LE, Davey Smith G, Neaton JD. ZIP-code-based versus tract-based income measures as long-term risk-adjusted mortality predictors. American Journal of Epidemiology. 164: 586-90. PMID 16893922 DOI: 10.1093/Aje/Kwj234 |
0.309 |
|
| 2006 |
Pett SL, Wand H, Law MG, Arduino R, Lopez JC, Knysz B, Pereira LC, Pollack S, Reiss P, Tambussi G, Abrams DI, Cooper DA, Darbyshire JH, Duncan WR, Emery S, ... ... Neaton JD, et al. Evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial (ESPRIT): Geographical and gender differences in the baseline characteristics of participants Hiv Clinical Trials. 7: 70-85. PMID 16798622 DOI: 10.1310/4733-Acqf-F3P4-2Qac |
0.409 |
|
| 2006 |
Mocroft A, Neaton J, Bebchuk J, Staszewski S, Antunes F, Knysz B, Law M, Phillips AN, Lundgren JD. The feasibility of clinical endpoint trials in HIV infection in the highly active antiretroviral treatment (HAART) era Clinical Trials. 3: 119-132. PMID 16773954 DOI: 10.1191/1740774506Cn138Oa |
0.39 |
|
| 2006 |
Ishani A, Grandits GA, Grimm RH, Svendsen KH, Collins AJ, Prineas RJ, Neaton JD. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial. Journal of the American Society of Nephrology : Jasn. 17: 1444-52. PMID 16611715 DOI: 10.1681/Asn.2005091012 |
0.352 |
|
| 2006 |
Eberly LE, Prineas R, Cohen JD, Vazquez G, Zhi X, Neaton JD, Kuller LH. Metabolic syndrome: risk factor distribution and 18-year mortality in the multiple risk factor intervention trial. Diabetes Care. 29: 123-30. PMID 16373907 DOI: 10.2337/Diacare.29.01.06.Dc05-1320 |
0.335 |
|
| 2005 |
MacArthur RD, Perez G, Walmsley S, Baxter JD, Mullin CM, Neaton JD. Comparison of prognostic importance of latest CD4+ cell count and HIV RNA levels in patients with advanced HIV infection on highly active antiretroviral therapy Hiv Clinical Trials. 6: 127-135. PMID 16192247 DOI: 10.1310/A9B9-Rqd7-U8Ka-503U |
0.341 |
|
| 2005 |
Loutfy MR, Walmsley SL, Mullin CM, Perez G, Neaton JD. CD4(+) cell count increase predicts clinical benefits in patients with advanced HIV disease and persistent viremia after 1 year of combination antiretroviral therapy. The Journal of Infectious Diseases. 192: 1407-11. PMID 16170758 DOI: 10.1086/466537 |
0.361 |
|
| 2005 |
Thomas AJ, Eberly LE, Neaton JD, Smith GD. Latino risk-adjusted mortality in the men screened for the Multiple Risk Factor Intervention Trial. American Journal of Epidemiology. 162: 569-78. PMID 16076831 DOI: 10.1093/Aje/Kwi220 |
0.358 |
|
| 2005 |
Thomas AJ, Eberly LE, Davey Smith G, Neaton JD, Stamler J. Race/ethnicity, income, major risk factors, and cardiovascular disease mortality. American Journal of Public Health. 95: 1417-23. PMID 16006418 DOI: 10.2105/Ajph.2004.048165 |
0.341 |
|
| 2005 |
Normand SL, Rector TS, Neaton JD, Piña IL, Lazar RM, Proestel SE, Fleischer DJ, Cohn JN, Spertus JA. Clinical and analytical considerations in the study of health status in device trials for heart failure. Journal of Cardiac Failure. 11: 396-403. PMID 15948091 DOI: 10.1016/J.Cardfail.2005.04.002 |
0.305 |
|
| 2005 |
Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, Neaton JD, Grimm RH, Hansson L, Lacourcière Y, Muller JE, Sleight P, Weber MA, White WB, Williams GH, Wittes J, et al. Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region. Journal of Hypertension. 23: 1099-106. PMID 15834298 DOI: 10.1097/01.Hjh.0000166853.26087.22 |
0.323 |
|
| 2004 |
DeMets D, Califf R, Dixon D, Ellenberg S, Fleming T, Held P, Julian D, Kaplan R, Levine R, Neaton J, Packer M, Pocock S, Rockhold F, Seto B, Siegel J, et al. Issues in regulatory guidelines for data monitoring committees Clinical Trials (London, England). 1: 162-169. PMID 16281888 DOI: 10.1191/1740774504Cn019Xx |
0.311 |
|
| 2004 |
Eberly LE, Neaton JD, Thomas AJ, Yu D. Multiple-stage screening and mortality in the Multiple Risk Factor Intervention Trial. Clinical Trials (London, England). 1: 148-61. PMID 16281887 DOI: 10.1191/1740774504Cn018Oa |
0.377 |
|
| 2004 |
Vaccaro O, Eberly LE, Neaton JD, Yang L, Riccardi G, Stamler J. Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial. Archives of Internal Medicine. 164: 1438-43. PMID 15249353 DOI: 10.1001/Archinte.164.13.1438 |
0.334 |
|
| 2004 |
Arduino RC, Nannini EC, Rodriguez-Barradas M, Schrader S, Losso M, Ruxrungtham K, Allende MC, Emery S, Fosdick L, Neaton J, Tavel JA, Davey RT, Lane HC. CD4 cell response to 3 doses of subcutaneous interleukin 2: meta-analysis of 3 Vanguard studies. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 39: 115-22. PMID 15206062 DOI: 10.1086/421775 |
0.301 |
|
| 2004 |
Perez G, MacArthur RD, Walmsley S, Baxter JA, Mullin C, Neaton JD. A randomized clinical trial comparing nelfinavir and ritonavir in patients with advanced HIV disease (CPCRA 042/CTN 102). Hiv Clinical Trials. 5: 7-18. PMID 15002082 DOI: 10.1310/N11F-Nk93-Mumr-A1Vv |
0.374 |
|
| 2004 |
Cohen JD, Prineas RJ, Zhi X, Eberly LE, Kuller LH, Neaton JD. 838-6 The impact of prior myocardial infarction, metabolic syndrome, and high white blood cell count on coronary heart disease mortality: The multiple risk factor intervention trial (MRFIT) 18-year follow-up experience Journal of the American College of Cardiology. 43: A416. DOI: 10.1016/S0735-1097(04)91755-X |
0.351 |
|
| 2003 |
Reisler RB, Han C, Burman WJ, Tedaldi EM, Neaton JD. Grade 4 events are as important as AIDS events in the era of HAART. Journal of Acquired Immune Deficiency Syndromes (1999). 34: 379-86. PMID 14615655 DOI: 10.1097/00126334-200312010-00004 |
0.335 |
|
| 2003 |
Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, Garside DB, Wilson PW. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. Jama. 290: 891-7. PMID 12928465 DOI: 10.1001/Jama.290.7.891 |
0.353 |
|
| 2003 |
Eberly LE, Stamler J, Neaton JD. Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease. Archives of Internal Medicine. 163: 1077-83. PMID 12742806 DOI: 10.1001/Archinte.163.9.1077 |
0.306 |
|
| 2003 |
Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, Neaton JD, Grimm RH, Hansson L, Lacourcière Y, Muller J, Sleight P, Weber MA, Williams G, Wittes J, et al. Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial Journal of the American Medical Association. 289: 2073-2082. PMID 12709465 DOI: 10.1001/Jama.289.16.2073 |
0.351 |
|
| 2003 |
Lane HC, Neaton JD. When to start therapy for HIV infection: a swinging pendulum in search of data. Annals of Internal Medicine. 138: 680-1. PMID 12693893 DOI: 10.7326/0003-4819-138-8-200304150-00018 |
0.335 |
|
| 2003 |
Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. The New England Journal of Medicine. 348: 1309-21. PMID 12668699 DOI: 10.1056/Nejmoa030207 |
0.343 |
|
| 2003 |
Neaton JD. Controlled Clinical Trials: Preface Controlled Clinical Trials. 24: 2-3. DOI: 10.1016/S0197-2456(00)00128-8 |
0.3 |
|
| 2002 |
Masur H, Kaplan JE, Holmes KK, Alston B, Alter MJ, Ampel N, Anderson JR, Baker AC, Barr D, Bartlett JG, Bennett JE, Benson CA, Bower WA, Bozzette SA, Brooks JT, ... ... Neaton J, et al. Guidelines for preventing opportunistic infections among HIV-infected persons - 2002 Annals of Internal Medicine. 137: 435-477. PMID 12617574 DOI: 10.7326/0003-4819-137-5_Part_2-200209031-00002 |
0.345 |
|
| 2002 |
Domanski M, Mitchell G, Pfeffer M, Neaton JD, Norman J, Svendsen K, Grimm R, Cohen J, Stamler J. Pulse pressure and cardiovascular disease-related mortality: Follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT) Journal of the American Medical Association. 287: 2677-2683. PMID 12020303 DOI: 10.1001/Jama.287.20.2677 |
0.358 |
|
| 2002 |
Baxter JD, Merigan TC, Wentworth DN, Neaton JD, Hoover ML, Hoetelmans RM, Piscitelli SC, Verbiest WH, Mayers DL. Both baseline HIV-1 drug resistance and antiretroviral drug levels are associated with short-term virologic responses to salvage therapy. Aids (London, England). 16: 1131-8. PMID 12004271 DOI: 10.1097/00002030-200205240-00006 |
0.302 |
|
| 2002 |
Emery S, Abrams DI, Cooper DA, Darbyshire JH, Lane HC, Lundgren JD, Neaton JD. The Evaluation of Subcutaneous Proleukin® (interleukin-2) in a Randomized International Trial: Rationale, design, and methods of ESPRIT Controlled Clinical Trials. 23: 198-220. PMID 11943448 DOI: 10.1016/S0197-2456(01)00179-9 |
0.38 |
|
| 2001 |
Black HR, Elliott WJ, Neaton JD, Grandits G, Grambsch P, Grimm RH, Hansson L, Lacoucière Y, Muller J, Sleight P, Weber MA, White WB, Williams G, Wittes J, Zanchetti A, et al. Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial. Hypertension (Dallas, Tex. : 1979). 37: 12-18. PMID 11208750 DOI: 10.1161/01.Hyp.37.1.12 |
0.3 |
|
| 2000 |
Babiker A, Bartlett J, Breckenridge A, Collins G, Coombs R, Cooper D, Creagh T, Cross A, Daniels M, Darbyshire J, Dawson D, DeGruttola V, DeMasi R, Dolin R, Eron J, ... ... Neaton J, et al. Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: A meta-analysis Aids Research and Human Retroviruses. 16: 1123-1133. PMID 10954887 DOI: 10.1089/088922200414965 |
0.311 |
|
| 2000 |
Stamler J, Daviglus ML, Garside DB, Dyer AR, Greenland P, Neaton JD. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity Journal of the American Medical Association. 284: 311-318. PMID 10891962 DOI: 10.1001/Jama.284.3.311 |
0.362 |
|
| 2000 |
Eberly LE, Ohman PA, Neaton JD, Price RW, Abrams DI. Kaposi's sarcoma and central nervous system disease: a real association or an artifact of the control group? Terry Beirn Community Programs for Clinical Research on AIDS. Aids (London, England). 14: 995-1000. PMID 10853981 DOI: 10.1097/00002030-200005260-00011 |
0.327 |
|
| 2000 |
Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, Konstam MA, Riegger G, Klinger GH, Neaton J, Sharma D, Thiyagarajan B. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomised trial - The Losartan Heart Failure Survival Study ELITE II Lancet. 355: 1582-1587. PMID 10821361 DOI: 10.1016/S0140-6736(00)02213-3 |
0.322 |
|
| 1999 |
Stamler J, Stamler R, Neaton JD, Wentworth D, Daviglus ML, Garside D, Dyer AR, Liu K, Greenland P. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy. Findings for 5 large cohorts of young adult and middle-aged men and women Journal of the American Medical Association. 282: 2012-2018. PMID 10591383 DOI: 10.1001/Jama.282.21.2012 |
0.357 |
|
| 1999 |
Pitt B, Poole-Wilson P, Segal R, Martinez FA, Dickstein K, Camm AJ, Konstam MA, Riegger G, Klinger GH, Neaton J, Sharma D, Thiyagarajan B. Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: Rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study - ELITE II Journal of Cardiac Failure. 5: 146-154. PMID 10404354 DOI: 10.1016/S1071-9164(99)90037-4 |
0.344 |
|
| 1998 |
Albert JM, Ioannidis JPA, Reichelderfer P, Conway B, Coombs RW, Crane L, Demasi R, Dixon DO, Flandre P, Hughes MD, Kalish LA, Larntz K, Lin D, Marschner IC, Muñoz A, ... ... Neaton J, et al. NIAID Workshop, Memphis, Tennessee, 25-26 March 1997: Statistical issues for HIV surrogate endpoints: Point/counterpoint Statistics in Medicine. 17: 2435-2462. PMID 9819838 DOI: 10.1002/(Sici)1097-0258(19981115)17:21<2435::Aid-Sim994>3.0.Co;2-G |
0.36 |
|
| 1998 |
Green LA, Rhame FS, Price RW, Perlman DC, Capps LG, Sampson JH, Deyton LR, Schnittman SM, Fisher EJ, Bartsch GE, Krum EA, Neaton JD. Experience with a cross-study endpoint review committee for AIDS clinical trials Aids. 12: 1983-1990. PMID 9814866 DOI: 10.1097/00002030-199815000-00009 |
0.361 |
|
| 1998 |
Capps L, Peng G, Doyle M, El-Sadr W, Neaton JD. Sexually transmitted infections in women infected with the human immunodeficiency virus Sexually Transmitted Diseases. 25: 443-447. PMID 9773440 DOI: 10.1097/00007435-199809000-00012 |
0.323 |
|
| 1998 |
Vaccaro O, Stamler J, Neaton JD. Sixteen-year coronary mortality in black and white men with diabetes screened for the Multiple Risk Factor Intervention Trial (MRFIT) International Journal of Epidemiology. 27: 636-641. PMID 9758118 DOI: 10.1093/Ije/27.4.636 |
0.368 |
|
| 1998 |
Davey Smith G, Neaton JD, Wentworth D, Stamler R, Stamler J. Mortality differences between black and white men in the USA: The contribution of income and other risk factors among men screened for the MRFIT Lancet. 351: 934-939. PMID 9734939 DOI: 10.1016/S0140-6736(00)80010-0 |
0.362 |
|
| 1998 |
Black HR, Elliott WJ, Neaton JD, Grandits G, Grambsch P, Grimm RH, Hansson L, Lacoucière Y, Muller J, Sleight P, Weber MA, White WB, Williams G, Wittes J, Zanchetti A, et al. Rationale and design for the controlled ONset Verapamil INvestigation of cardiovascular endpoints (CONVINCE) trial Controlled Clinical Trials. 19: 370-390. PMID 9683312 DOI: 10.1016/S0197-2456(98)00013-0 |
0.38 |
|
| 1998 |
Lund EM, James KM, Neaton JD. Veterinary randomized clinical trial reporting: a review of the small animal literature. Journal of Veterinary Internal Medicine / American College of Veterinary Internal Medicine. 12: 57-60. PMID 9560759 DOI: 10.1111/J.1939-1676.1998.Tb02095.X |
0.314 |
|
| 1998 |
Torres RA, Neaton JD, Wentworth DN, Barr MR, Abrams D, Sherer R, Ward T, Sampson J. Acyclovir use and survival among human immunodeficiency virus-infected patients with CD4 cell counts of <500/mm3 Clinical Infectious Diseases. 26: 85-90. PMID 9455514 DOI: 10.1086/516272 |
0.308 |
|
| 1997 |
Brancati FL, Whelton PK, Randall BL, Neaton JD, Stamler J, Klag MJ. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. Jama. 278: 2069-74. PMID 9403420 DOI: 10.1001/Jama.278.23.2069 |
0.311 |
|
| 1997 |
Coughlin SS, Neaton JD, Randall B, Sengupta A. Predictors of mortality from kidney cancer in 332,547 men screened for the Multiple Risk Factor Intervention Trial. Cancer. 79: 2171-7. PMID 9179064 DOI: 10.1002/(Sici)1097-0142(19970601)79:11<2171::Aid-Cncr15>3.0.Co;2-T |
0.344 |
|
| 1997 |
el-Sadr W, Neaton JD. Annotation: wanted--a simple and meaningful HIV staging system American Journal of Public Health. 87: 546-548. PMID 9146427 DOI: 10.2105/Ajph.87.4.546 |
0.302 |
|
| 1996 |
Burns DN, Hillman D, Neaton JD, Sherer R, Mitchell T, Capps L, Vallier WG, Thurnherr MD, Gordin FM. Cigarette smoking, bacterial pneumonia, and other clinical outcomes in HIV-1 infection Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 13: 374-383. PMID 8948377 DOI: 10.1097/00042560-199612010-00012 |
0.354 |
|
| 1996 |
Larntz K, Neaton JD, Wentworth DN, Yurik T. Data analysis issues for protocols with overlapping enrollment Statistics in Medicine. 15: 2445-2453. PMID 8931212 DOI: 10.1002/(Sici)1097-0258(19961130)15:22<2445::Aid-Sim462>3.0.Co;2-8 |
0.346 |
|
| 1996 |
Saravolatz L, Neaton JD, Sacks L, Deyton L, Rhame F, Sherer R. CD4+ T lymphocyte counts and patterns of mortality among patients infected with human immunodeficiency virus who were enrolled in community programs for clinical research on AIDS. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 22: 513-20. PMID 8852972 DOI: 10.1093/Clinids/22.3.513 |
0.337 |
|
| 1996 |
Smith GD, Neaton JD, Wentworth D, Stamler R, Stamler J. Socioeconomic differentials in mortality risk among men screened for the multiple risk factor intervention trial: I. White men American Journal of Public Health. 86: 486-496. PMID 8604778 DOI: 10.2105/Ajph.86.4.486 |
0.385 |
|
| 1995 |
Chan IS, Neaton JD, Saravolatz LD, Crane LR, Osterberger J. Frequencies of opportunistic diseases prior to death among HIV-infected persons. Community Programs for Clinical Research on AIDS. Aids (London, England). 9: 1145-51. PMID 8519450 DOI: 10.1097/00002030-199510000-00005 |
0.363 |
|
| 1995 |
Liebson PR, Grandits GA, Dianzumba S, Prineas RJ, Grimm RH, Neaton JD, Stamler J. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the treatment of mild hypertension study (TOMHS) Circulation. 91: 698-706. PMID 7828296 DOI: 10.1161/01.Cir.91.3.698 |
0.318 |
|
| 1995 |
Flack JM, Neaton J, Grimm R, Shih J, Cutler J, Ensrud K, MacMahon S. Blood pressure and mortality among men with prior myocardial infarction. Multiple Risk Factor Intervention Trial Research Group. Circulation. 92: 2437-45. PMID 7586343 DOI: 10.1161/01.Cir.92.9.2437 |
0.348 |
|
| 1994 |
Coughlin SS, Neaton JD, Sengupta A, Kuller LH. Predictors of mortality from idiopathic dilated cardiomyopathy in 356,222 men screened for the Multiple Risk Factor Intervention Trial. American Journal of Epidemiology. 139: 166-72. PMID 8296783 DOI: 10.1093/Oxfordjournals.Aje.A116978 |
0.382 |
|
| 1994 |
Jacobson MA, Besch CL, Child C, Hafner R, Matts JP, Muth K, Wentworth DN, Neaton JD, Abrams D, Rimland D. Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immunodeficiency virus disease: results of a randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS. The Journal of Infectious Diseases. 169: 384-94. PMID 8106772 DOI: 10.1093/Infdis/169.2.384 |
0.416 |
|
| 1994 |
Sampson J, Neaton J. On being poor with HIV The Lancet. 344: 1100-1101. PMID 7934488 DOI: 10.1016/S0140-6736(94)90623-8 |
0.318 |
|
| 1994 |
Abrams DI, Goldman AI, Launer C, Korvick JA, Neaton JD, Crane LR, Grodesky M, Wakefield S, Muth K, Kornegay S. A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. The Terry Beirn Community Programs for Clinical Research on AIDS. The New England Journal of Medicine. 330: 657-62. PMID 7906384 DOI: 10.1056/Nejm199403103301001 |
0.359 |
|
| 1994 |
Neaton JD, Wentworth DN, Rhame F, Hogan C, Abrams DI, Deyton L. Considerations in choice of a clinical endpoint for AIDS clinical trials Statistics in Medicine. 13: 2107-2125. PMID 7846414 DOI: 10.1002/Sim.4780131919 |
0.38 |
|
| 1994 |
Egger M, Neaton JD, Phillips AN, Smith GD, Graham NMH, Montaner JSG, Raboud J, O'Shaughnessy M, Laing PA, Gore SM, Bird AG, Hirschel B, Aboulker J-, Babiker AG, Darbyshire JH, et al. Concorde trial of immediate versus deferred zidovudine The Lancet. 343: 1355-1358. DOI: 10.1016/S0140-6736(94)92490-2 |
0.318 |
|
| 1993 |
Flack JM, Neaton JD, Daniels B, Esunge P. Ethnicity and renal disease: lessons from the Multiple Risk Factor Intervention Trial and the Treatment of Mild Hypertension Study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 21: 31-40. PMID 8465834 DOI: 10.1016/S0272-6386(12)80859-6 |
0.341 |
|
| 1993 |
Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data Archives of Internal Medicine. 153: 598-615. PMID 8439223 DOI: 10.1001/Archinte.153.5.598 |
0.344 |
|
| 1993 |
Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial Diabetes Care. 16: 434-444. PMID 8432214 DOI: 10.2337/Diacare.16.2.434 |
0.336 |
|
| 1993 |
Eichner JE, Kuller LH, Orchard TJ, Grandits GA, McCallum LM, Ferrell RE, Neaton JD. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. The American Journal of Cardiology. 71: 160-5. PMID 8421977 DOI: 10.1016/0002-9149(93)90732-R |
0.325 |
|
| 1993 |
Stamler J, Dyer AR, Shekelle RB, Neaton J, Stamler R. Relationship of baseline major risk factors to coronary and all-cause mortality, and to longevity: findings from long-term follow-up of Chicago cohorts. Cardiology. 82: 191-222. PMID 8324780 DOI: 10.1159/000175868 |
0.362 |
|
| 1993 |
Shaten BJ, Smith GD, Kuller LH, Neaton JD. Risk factors for the development of type II diabetes among men enrolled in the Usual Care group of the Multiple Risk Factor Intervention Trial Diabetes Care. 16: 1331-1339. PMID 8269790 DOI: 10.2337/Diacare.16.10.1331 |
0.305 |
|
| 1993 |
Neaton JD. Renal Disease in Hypertensive Blacks: MRFIT-Reply Jama: the Journal of the American Medical Association. 269: 2630. DOI: 10.1001/Jama.1993.03500200043030 |
0.324 |
|
| 1992 |
Neaton JD, Wentworth D. Serum Cholesterol, Blood Pressure, Cigarette Smoking, and Death From Coronary Heart Disease: Overall Findings and Differences by Age for 316099 White Men Archives of Internal Medicine. 152: 56-64. PMID 1728930 DOI: 10.1001/Archinte.1992.00400130082009 |
0.365 |
|
| 1992 |
Neaton JD, Blackburn H, Jacobs D, Kuller L, Lee DJ, Sherwin R, Shih J, Stamler J, Wentworth D. Serum Cholesterol Level and Mortality Findings for Men Screened in the Multiple Risk Factor Intervention Trial Archives of Internal Medicine. 152: 1490-1500. PMID 1627030 DOI: 10.1001/Archinte.1992.00400190110021 |
0.336 |
|
| 1992 |
Smith GD, Neaton JD, Ben-shlomo Y, Shipley M, Wentworth D. Serum cholesterol concentration and primary malignant brain tumors: A prospective study American Journal of Epidemiology. 135: 259-265. PMID 1546701 DOI: 10.1093/Oxfordjournals.Aje.A116279 |
0.302 |
|
| 1992 |
Neaton JD, Bartsch GE. Impact of measurement error and temporal variability on the estimation of event probabilities for risk factor intervention trials Statistics in Medicine. 11: 1719-1729. PMID 1485055 DOI: 10.1002/Sim.4780111306 |
0.318 |
|
| 1992 |
Phillips AN, Neaton JD, Cook DG, Grimm RH, Shaper AG. Leukocyte count and risk of major coronary heart disease events American Journal of Epidemiology. 136: 59-70. PMID 1415132 DOI: 10.1093/Oxfordjournals.Aje.A116421 |
0.347 |
|
| 1992 |
Jacobs D, Blackburn H, Higgins M, Reed D, Iso H, McMillan G, Neaton J, Nelson J, Potter J, Rifkind B. Report of the Conference on Low Blood Cholesterol: Mortality Associations. Circulation. 86: 1046-60. PMID 1355411 DOI: 10.1161/01.Cir.86.3.1046 |
0.308 |
|
| 1992 |
Neaton JD. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group Archives of Internal Medicine. 152: 1490-1500. DOI: 10.1001/Archinte.152.7.1490 |
0.344 |
|
| 1991 |
Shaten BJ, Kuller LH, Neaton JD. Association between baseline risk factors, cigarette smoking, and CHD mortality after 10.5 years Preventive Medicine. 20: 655-669. PMID 1758844 DOI: 10.1016/0091-7435(91)90061-8 |
0.342 |
|
| 1991 |
Neaton JD, Bartsch GE, Broste SK, Cohen JD, Simon NM. A case of data alteration in the Multiple Risk Factor Intervention Trial (MRFIT) Controlled Clinical Trials. 12: 731-740. PMID 1665114 DOI: 10.1016/0197-2456(91)90036-L |
0.321 |
|
| 1990 |
Grimm RH, Neaton JD, Elmer PJ, Svendsen KH, Levin J, Segal M, Holland L, Witte LJ, Clearman DR, Kofron P. The influence of oral potassium chloride on blood pressure in hypertensive men on a low-sodium diet. The New England Journal of Medicine. 322: 569-74. PMID 2406601 DOI: 10.1056/Nejm199003013220901 |
0.313 |
|
| 1990 |
Mascioli SR, Grimm RH, Neaton JD, Stamler J, Prineas RJ, Cutler JA, Elmer PJ, McDonald R, Schnaper H, Schoenberger J. Characteristics of participants at baseline in the Treatment of Mild Hypertension Study (TOMHS) The American Journal of Cardiology. 66. PMID 2220647 DOI: 10.1016/0002-9149(90)90760-X |
0.346 |
|
| 1990 |
Hansen LK, Grimm RH, Neaton JD. The relationship of white blood cell count to other cardiovascular risk factors International Journal of Epidemiology. 19: 881-888. PMID 2084016 DOI: 10.1093/Ije/19.4.881 |
0.3 |
|
| 1990 |
MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 335: 765-74. PMID 1969518 DOI: 10.1016/0140-6736(90)90878-9 |
0.336 |
|
| 1989 |
Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR, Bangdiwala S, Tyroler HA. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 79: 8-15. PMID 2642759 DOI: 10.1161/01.Cir.79.1.8 |
0.39 |
|
| 1989 |
Iso H, Jacobs DR, Wentworth D, Neaton JD, Cohen JD. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial New England Journal of Medicine. 320: 904-910. PMID 2619783 DOI: 10.1056/Nejm198904063201405 |
0.329 |
|
| 1989 |
MacMahon S, Collins G, Rautaharju P, Cutler J, Neaton J, Prineas R, Crow R, Stamler J. Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the Multiple Risk Factor Intervention Trial. The American Journal of Cardiology. 63: 202-10. PMID 2521269 DOI: 10.1016/0002-9149(89)90286-5 |
0.325 |
|
| 1989 |
Stamler J, Neaton JD, Wentworth DN. Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease Hypertension. 13: I-3-I-12. PMID 2490825 DOI: 10.1161/01.Hyp.13.5_Suppl.I2 |
0.375 |
|
| 1988 |
Rutan GH, Kuller LH, Neaton JD, Wentworth DN, McDonald RH, McFate Smith W. Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial Circulation. 77: 504-514. PMID 3277736 DOI: 10.1161/01.Cir.77.3.504 |
0.367 |
|
| 1988 |
Grimm RH, Kofron PM, Neaton JD, Svendsen KH, Elmer PJ, Holland L, Witte L, Clearman D, Prineas RJ. Effect of potassium supplementation combined with dietary sodium reduction on blood pressure in men taking antihypertensive medication Journal of Hypertension, Supplement. 6: S591-S593. PMID 3241259 DOI: 10.1097/00004872-198812040-00185 |
0.309 |
|
| 1987 |
Abdalla IS, Prineas RJ, Neaton JD, Jacobs DR, Crow RS. Relation between ventricular premature complexes and sudden cardiac death in apparently healthy men. The American Journal of Cardiology. 60: 1036-42. PMID 3673904 DOI: 10.1016/0002-9149(87)90348-1 |
0.356 |
|
| 1987 |
Neaton JD, Grimm RH, Cutler JA. Recruitment of participants for the Multiple Risk Factor Intervention Trial (MRFIT) Controlled Clinical Trials. 8: 41-53. PMID 3440389 DOI: 10.1016/0197-2456(87)90006-7 |
0.374 |
|
| 1987 |
Stamler J, Prineas RJ, Neaton JD, Grimm RH, McDonald RH, Schnaper HW, Schoenberger JA, Elmer PJ, Cutler JA. Background and design of the new U.S. trial on diet and drug treatment of "mild" hypertension (TOMHS) The American Journal of Cardiology. 59. PMID 3296721 DOI: 10.1016/0002-9149(87)90158-5 |
0.354 |
|
| 1987 |
Cohen JD, Neaton JD, Prineas RJ, Daniels KA. Diuretics, serum potassium and ventricular arrhythmias in the Multiple Risk Factor Intervention Trial. The American Journal of Cardiology. 60: 548-54. PMID 2442992 DOI: 10.1016/0002-9149(87)90303-1 |
0.361 |
|
| 1986 |
Watkins LO, Neaton JD, Kuller LH. Racial differences in high-density lipoprotein cholesterol and coronary heart disease incidence in the usual-care group of the multiple risk factor intervention trial The American Journal of Cardiology. 57: 538-545. PMID 3953436 DOI: 10.1016/0002-9149(86)90831-3 |
0.339 |
|
| 1986 |
Stamler J, Wentworth D, Neaton JD. Prevalence and prognostic significance of hypercholesterolemia in men with hypertension: Prospective data on the primary screenees of the multiple risk factor intervention trial The American Journal of Medicine. 80: 33-39. PMID 3946459 DOI: 10.1016/0002-9343(86)90158-0 |
0.366 |
|
| 1986 |
DuChene AG, Hultgren DH, Neaton JD, Grambsch PV, Broste SK, Aus BM, Rasmussen WL. Forms control and error detection procedures used at the Coordinating Center of the Multiple Risk Factor Intervention Trial (MRFIT). Controlled Clinical Trials. 7: 34S-45S. PMID 3802845 DOI: 10.1016/0197-2456(86)90158-3 |
0.307 |
|
| 1986 |
Stamler J, Wentworth D, Neaton JD. Is Relationship Between Serum Cholesterol and Risk of Premature Death From Coronary Heart Disease Continuous and Graded?: Findings in 356 222 Primary Screenees of the Multiple Risk Factor Intervention Trial (MRFIT) Jama: the Journal of the American Medical Association. 256: 2823-2828. PMID 3773199 DOI: 10.1001/Jama.1986.03380200061022 |
0.367 |
|
| 1986 |
Rautaharju PM, Prineas RJ, Eifler WJ, Furberg CD, Neaton JD, Crow RS, Stamler J, Cutler JA. Prognostic value of exercise electrocardiogram in men at high risk of future coronary heart disease: Multiple Risk Factor Intervention Trial experience. Journal of the American College of Cardiology. 8: 1-10. PMID 3711503 DOI: 10.1016/S0735-1097(86)80084-5 |
0.34 |
|
| 1986 |
Kannel WB, Neaton JD, Wentworth D, Thomas HE, Stamler J, Hulley SB, Kjelsberg MO. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT American Heart Journal. 112: 825-836. PMID 3532744 DOI: 10.1016/0002-8703(86)90481-3 |
0.36 |
|
| 1986 |
Kuller LH, Hulley SB, Cohen JD, Neaton J. Unexpected effects of treating hypertension in men with electrocardiographic abnormalities: a critical analysis. Circulation. 73: 114-123. PMID 2416486 DOI: 10.1161/01.Cir.73.1.114 |
0.393 |
|
| 1985 |
Grimm RH, Neaton JD, Ludwig W. Prognostic Importance of the White Blood Cell Count for Coronary, Cancer, and All-Cause Mortality Jama: the Journal of the American Medical Association. 254: 1932-1937. PMID 4046122 DOI: 10.1001/Jama.1985.03360140090031 |
0.353 |
|
| 1985 |
Shekelle RB, Hulley SB, Neaton JD, Billings JH, Borhani NO, Gerace TA, Jacobs DR, Lasser NL, Mittlemark MB, Stamler J. The mrfit behavior pattern study: II. Type a behavior and incidence of coronary heart disease American Journal of Epidemiology. 122: 559-570. PMID 4025299 DOI: 10.1093/Oxfordjournals.Aje.A114135 |
0.333 |
|
| 1985 |
Cutler JA, Neaton JD, Hulley SB, Kuller L, Paul O, Stamler J. Coronary heart disease and all-causes mortality in the multiple risk factor intervention trial: Subgroup findings and comparisons with other trials Preventive Medicine. 14: 293-311. PMID 3903734 DOI: 10.1016/0091-7435(85)90058-1 |
0.401 |
|
| 1985 |
Grimm RH, Neaton JD, McDonald M, Case J, McGill E, Allen R, Bailey-Hoffman G, Kousch D, Childs J, Hulley SB. Beneficial effects from systematic dosage reduction of the diuretic, chlorthalidone: A randomized study within a clinical trial American Heart Journal. 109: 858-864. PMID 3885701 DOI: 10.1016/0002-8703(85)90651-9 |
0.303 |
|
| 1985 |
Grimm RH, Cohen JD, Smith WM, Falvo Gerard L, Neaton JD. Hypertension Management in the Multiple Risk Factor Intervention Trial (MRFIT): Six-Year Intervention Results for Men in Special Intervention and Usual Care Groups Archives of Internal Medicine. 145: 1191-1199. DOI: 10.1001/Archinte.1985.00360070061010 |
0.347 |
|
| 1984 |
Neaton JD, Kuller LH, Wentworth D, Borhani NO. Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years American Heart Journal. 108: 759-770. PMID 6475745 DOI: 10.1016/0002-8703(84)90669-0 |
0.332 |
|
| 1983 |
Wentworth DN, Neaton JD, Rasmussen WL. An evaluation of the Social Security Administration master beneficiary record file and the National Death Index in the ascertainment of vital status. American Journal of Public Health. 73: 1270-4. PMID 6625030 DOI: 10.2105/Ajph.73.11.1270 |
0.316 |
|
| 1981 |
Neaton JD, Broste S, Cohen L, Fishman EL, Kjelsberg MO, Schoenberger J. The multiple risk factor intervention trial (MRFIT). VII. A comparison of risk factor changes between the two study groups Preventive Medicine. 10: 519-543. PMID 7027241 DOI: 10.1016/0091-7435(81)90063-3 |
0.328 |
|
| 1980 |
Kuller L, Neaton J, Caggiula A, Falvo-Gerard L. Primary prevention of heart attacks: the multiple risk factor intervention trial. American Journal of Epidemiology. 112: 185-99. PMID 6998287 DOI: 10.1093/Oxfordjournals.Aje.A112984 |
0.346 |
|
| Show low-probability matches. |